Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
17.75
+0.25 (1.43%)
Jul 15, 2025, 2:45 PM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
191.48224.16362.07269.23254.37103.98
Upgrade
Trading Asset Securities
22.617.509020010
Upgrade
Cash & Short-Term Investments
214.08241.66362.07359.23454.37113.98
Upgrade
Cash Growth
-33.58%-33.26%0.79%-20.94%298.63%19.21%
Upgrade
Accounts Receivable
555.34570.35491.55491.69342.52192.26
Upgrade
Other Receivables
2.0211.13.781.10.81
Upgrade
Receivables
557.35571.35492.65495.48343.62193.06
Upgrade
Inventory
85.1585.6872.1278.5274.546
Upgrade
Prepaid Expenses
--000.06-
Upgrade
Other Current Assets
7.99.454.352.662.429.71
Upgrade
Total Current Assets
864.48908.14931.19935.89874.98362.76
Upgrade
Property, Plant & Equipment
581.94572.3425.87378.35259.27240.39
Upgrade
Other Intangible Assets
16.0316.3316.8217.5113.7812.22
Upgrade
Long-Term Deferred Tax Assets
18.2118.2114.079.567.11-
Upgrade
Long-Term Deferred Charges
293.16291.5195.76132.3134.9319.74
Upgrade
Other Long-Term Assets
0.220.5628.895.2421.826.15
Upgrade
Total Assets
1,7741,8071,6131,4791,212641.26
Upgrade
Accounts Payable
79.8786.2940.0680.6834.2833.08
Upgrade
Accrued Expenses
0.49368.06346.13321.65251.98167.58
Upgrade
Short-Term Debt
19.224.224.2853525
Upgrade
Current Portion of Long-Term Debt
81.3587.4231.6910--
Upgrade
Current Income Taxes Payable
8.269.443.749.464.03-
Upgrade
Current Unearned Revenue
2.030.513.626.717.52.56
Upgrade
Other Current Liabilities
347.1119.6726.7911.738.8811.6
Upgrade
Total Current Liabilities
538.3595.59476.22525.23341.66239.83
Upgrade
Long-Term Debt
278.5249.53177.2929.99--
Upgrade
Long-Term Leases
0.660.644.439.043.252.49
Upgrade
Long-Term Unearned Revenue
2524.7919.9820.1118.6719.13
Upgrade
Long-Term Deferred Tax Liabilities
2.462.462.722.562.3-
Upgrade
Other Long-Term Liabilities
0.740.531.210.091.332.84
Upgrade
Total Liabilities
845.66873.54681.84587.02367.22264.29
Upgrade
Common Stock
405.93405.93406.16405.27405.27364.74
Upgrade
Additional Paid-In Capital
607.91606605.75580.95570.56251.37
Upgrade
Retained Earnings
-88.77-81.7-87.04-104.59-131.17-239.13
Upgrade
Treasury Stock
-5.56-5.56-7.96---
Upgrade
Total Common Equity
919.51924.68916.91881.63844.66376.97
Upgrade
Minority Interest
8.868.8213.8610.22--
Upgrade
Shareholders' Equity
928.37933.5930.77891.85844.66376.97
Upgrade
Total Liabilities & Equity
1,7741,8071,6131,4791,212641.26
Upgrade
Total Debt
379.71361.79237.61134.0338.2527.49
Upgrade
Net Cash (Debt)
-165.63-120.13124.47225.2416.1186.49
Upgrade
Net Cash Growth
---44.73%-45.88%381.08%0.86%
Upgrade
Net Cash Per Share
-0.41-0.300.310.561.080.24
Upgrade
Filing Date Shares Outstanding
405.93405.93406.16405.27405.27364.74
Upgrade
Total Common Shares Outstanding
405.93405.93406.16405.27405.27364.74
Upgrade
Working Capital
326.18312.55454.97410.67533.31122.93
Upgrade
Book Value Per Share
2.272.282.262.182.081.03
Upgrade
Tangible Book Value
903.48908.35900.08864.11830.88364.75
Upgrade
Tangible Book Value Per Share
2.232.242.222.132.051.00
Upgrade
Buildings
-224.6996.22103.17103.17-
Upgrade
Machinery
-318.26299.39261.88245.29-
Upgrade
Construction In Progress
-211.27181.35135.4911.63-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.